EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Post‐Translational Modifications of Key Proteins in Hematologic Malignancies: Carcinogenic Mechanisms, Biomarker Potential, and New Therapeutic Strategies

Yuxuan Han, Chaowei Zhang, Weiyi Yao, Qing Hong, Xinyu Tang, Yanan Zhu, Na Chen

iLABMED · 2026-06 · 4 (2) · 91-107

DOI: 10.1002/ila2.70064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift iLABMED, online erschienen am 11.06.2026. Verfasst von Yuxuan Han und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post‐translational modifications (PTMs) of proteins have emerged as critical regulators in the pathogenesis of hematologic malignancies. This review synthesizes the latest research advances in the regulatory mechanisms, clinical relevance, and translational application of diverse PTMs, including phosphorylation, acetylation, succinylation, and lactylation, in blood cancers. We summarize how these modifications dynamically regulate the stability and interaction of key oncogenic proteins, thereby orchestrating tumor proliferation, apoptosis evasion, and chemotherapy resistance. Crucially, this article emphasizes the clinical potential of PTMs beyond therapeutic targeting, highlighting their emerging role as sensitive biomarkers for early diagnosis. By identifying the specific PTM landscapes across leukemias, lymphomas, and myeloma, we provide a framework for developing next‐generation diagnostic tools and precision therapies for hematologic malignancies.

Zitieren

APA

Han, Y., Zhang, C., Yao, W., Hong, Q., Tang, X., Zhu, Y., & Chen, N. (2026). Post‐Translational Modifications of Key Proteins in Hematologic Malignancies: Carcinogenic Mechanisms, Biomarker Potential, and New Therapeutic Strategies. iLABMED, 4(2), 91-107. https://doi.org/10.1002/ila2.70064

Vancouver

Han Y, Zhang C, Yao W, Hong Q, Tang X, Zhu Y, et al. Post‐Translational Modifications of Key Proteins in Hematologic Malignancies: Carcinogenic Mechanisms, Biomarker Potential, and New Therapeutic Strategies. iLABMED. 2026;4(2):91-107. doi:10.1002/ila2.70064

BibTeX
@article{Han2026,
  author = {Han, Yuxuan and Zhang, Chaowei and Yao, Weiyi and Hong, Qing and Tang, Xinyu and Zhu, Yanan and Chen, Na},
  title = {Post‐Translational Modifications of Key Proteins in Hematologic Malignancies: Carcinogenic Mechanisms, Biomarker Potential, and New Therapeutic Strategies},
  journal = {iLABMED},
  year = {2026},
  volume = {4},
  number = {2},
  pages = {91--107},
  doi = {10.1002/ila2.70064}
}
Kostenlos starten →